Whitefort Capital Management »

Arbutus Biopharma shares owned by Whitefort Capital Management

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Whitefort Capital Management from 13F filings

Historical chart of Whitefort Capital Management investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Whitefort Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Whitefort Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $33M 13M 2.50
2023-09-30 $24M 12M 2.03
2023-06-30 $19M 8.1M 2.30
2023-03-31 $23M 7.5M 3.03
2022-12-31 $9.0M 3.9M 2.33

More positions owned by Whitefort Capital Management

Global Ship Lease Com Cl A (GSL)
Arbutus Biopharma (ABUS)
Roivant Sciences SHS (ROIV)
Liberty Media Corp Del Com Lbty Srm S C (LSXMK)
Nextnav Common Stock (NN)
Genworth Finl Com Cl A (GNW)
Sabre Glbl Note 4.000% 4/1 (Principal)
Maiden Holdings SHS (MHLD)
Liberty Media Corp Del Com Lbty Liv S C (LLYVK)
Central Europe and Russia Fund (CEE)
Esperion Therapeutics Inc Ne Note 4.000% 11/1 (Principal)
Liquidia Corporation Com New (LQDA)
Esperion Therapeutics (ESPR)
Odyssey Marine Expl Com New (OMEX)
Innovate Corp Note 7.500% 8/0 (Principal)

View all positions for Whitefort Capital Management

Top funds holding Arbutus Biopharma

Whitefort Capital Management
Vanguard Group
Hudson Bay Capital Management
ADAR1 Capital Management
Centiva Capital
Citadel Advisors
Millennium Management
Advisor Group Holdings
FourWorld Capital Management
Citigroup
Caption Management
Bank of New York Mellon
Kennedy Capital Management
Barclays
Bank Of Montreal

View all funds holding Arbutus Biopharma